The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Lysenko A.V.
Petrovsky Russian Scientific Center of Surgery
Analysis of differential gene expression in myocardial tissue from patients with hypertrophic cardiomyopathy
Journal: Molecular Genetics, Microbiology and Virology. 2025;43(1): 17‑23
Views: 168
Downloaded: 0
To cite this article:
Klass AL, Slominsky PA, Vlasov IN, et al. . Analysis of differential gene expression in myocardial tissue from patients with hypertrophic cardiomyopathy. Molecular Genetics, Microbiology and Virology.
2025;43(1):17‑23. (In Russ.)
https://doi.org/10.17116/molgen20254301117
Hypertrophic cardiomyopathy (HCM) is one of the most prevalent myocardial diseases with a population frequency of 1:500—1:200. HCM is characterized by severe left ventricular hypertrophy (LVH), sometimes accompanied by outflow tract obstruction. Clinical manifestations of HCM range from minimal myocardial dysfunction to progressive heart failure (HF) and sudden cardiac death (SCD). This disease is characterized by significant genetic heterogeneity, moreover 60—70% of pathogenetically significant variants identified in patients residing in myosin-binding protein C (MYBPC3) and myosin heavy chain (MYH7) genes. Furthermore, in 40% of patients with a clinical diagnosis of HCM no mutations in causal genes are detected, nor is there a family history of the disease. One of the existing approaches to studying the etiopathogenesis of HCM is the study of hypertrophied myocardium and in this connection the aim of the presented work was to analyze gene expression in myocardial tissues in patients with HCM.
In this study we analyzed the transcriptome of myocardial tissues from patients with severe HCM undergoing surgical septal reduction therapy using whole transcriptome sequencing and real-time qRT-PCR.
Increased expression of PLCB1 and ADAMTS10 genes was shown in hypertrophic myocardial tissue of patients with familial HCM compared to non-familial cases.
Higher expression levels of PLCB1 and ADAMTS10 genes in patients with familial HCM can indicate the presence of specific molecular and genetic processes involved in both extracellular matrix remodeling and intracellular Gq-signaling.
Keywords:
Authors:
Lysenko A.V.
Petrovsky Russian Scientific Center of Surgery
Received:
25.11.2024
Accepted:
13.12.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.